Revised planning permission has been received for the repurposing of 17 Columbus Courtyard, Canary Wharf, into circa 200,000 sq ft of flexible lab and office space spanning nine upper floors.
Oaktree Capital Management, supported by LS Estates, intends to transform the existing office building into state-of-the-art life sciences space.
Designed by architects Scott Brownrigg, with guidance from planning advisor Avison Young, the repurposing of 17 Columbus Courtyard will align with the UKGBC Net Zero Carbon Framework, minimising both embodied and operational carbon.
It is intended that as much of the existing structure as possible will be retained and repurposed, diverting at least 98% of construction waste from landfill.
The ground and first floors of the BREEAM Excellent rated building will cater for ‘late-stage’ start-ups with the upper floors targeting larger occupiers. It is anticipated the redevelopment will be finished by Q3 2025.
Paul Bailey, managing director of life sciences at LS Estates, said: “We have begun to witness the emergence of Canary Wharf as a new life sciences cluster within London and 17 Columbus Courtyard will be one of the first lab-enabled buildings of scale to satisfy that increasing demand. With flexible floorspace and specification options available, we feel that occupiers will be able to focus on growing their businesses in a suitably collaborative environment.”
